228 related articles for article (PubMed ID: 27773784)
1. Treatment of brain metastases in the modern genomic era.
Dagogo-Jack I; Gill CM; Cahill DP; Santagata S; Brastianos PK
Pharmacol Ther; 2017 Feb; 170():64-72. PubMed ID: 27773784
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling of brain metastases: current knowledge and new frontiers.
Neagu MR; Gill CM; Batchelor TT; Brastianos PK
Chin Clin Oncol; 2015 Jun; 4(2):22. PubMed ID: 26112808
[TBL] [Abstract][Full Text] [Related]
3. Sequencing brain metastases and opportunities for targeted therapies.
Chukwueke UN; Brastianos PK
Pharmacogenomics; 2017 Apr; 18(6):585-594. PubMed ID: 28290769
[TBL] [Abstract][Full Text] [Related]
4. Targeted Treatment of Brain Metastases.
Shonka N; Venur VA; Ahluwalia MS
Curr Neurol Neurosci Rep; 2017 Apr; 17(4):37. PubMed ID: 28326470
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
6. Current chemotherapeutic regimens for brain metastases treatment.
Nam JY; O'Brien BJ
Clin Exp Metastasis; 2017 Oct; 34(6-7):391-399. PubMed ID: 28918542
[TBL] [Abstract][Full Text] [Related]
7. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
8. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
9. The future of targeted therapies for brain metastases.
Berghoff AS; Preusser M
Future Oncol; 2015; 11(16):2315-27. PubMed ID: 26260810
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and the treatment of brain metastases.
Peak S; Abrey LE
Hematol Oncol Clin North Am; 2006 Dec; 20(6):1287-95. PubMed ID: 17113463
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer brain metastasis: molecular mechanisms and directions for treatment.
Pedrosa RMSM; Mustafa DA; Soffietti R; Kros JM
Neuro Oncol; 2018 Oct; 20(11):1439-1449. PubMed ID: 29566179
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases in breast cancer.
Sim HW; Morris PG; Patil S; Khasraw M
Expert Rev Anticancer Ther; 2014 Feb; 14(2):173-83. PubMed ID: 24308683
[TBL] [Abstract][Full Text] [Related]
13. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Brastianos PK; Carter SL; Santagata S; Cahill DP; Taylor-Weiner A; Jones RT; Van Allen EM; Lawrence MS; Horowitz PM; Cibulskis K; Ligon KL; Tabernero J; Seoane J; Martinez-Saez E; Curry WT; Dunn IF; Paek SH; Park SH; McKenna A; Chevalier A; Rosenberg M; Barker FG; Gill CM; Van Hummelen P; Thorner AR; Johnson BE; Hoang MP; Choueiri TK; Signoretti S; Sougnez C; Rabin MS; Lin NU; Winer EP; Stemmer-Rachamimov A; Meyerson M; Garraway L; Gabriel S; Lander ES; Beroukhim R; Batchelor TT; Baselga J; Louis DN; Getz G; Hahn WC
Cancer Discov; 2015 Nov; 5(11):1164-1177. PubMed ID: 26410082
[TBL] [Abstract][Full Text] [Related]
14. How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases.
Angeli E; Nguyen TT; Janin A; Bousquet G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861465
[TBL] [Abstract][Full Text] [Related]
15. CNS metastasis: an old problem in a new guise.
Aragon-Ching JB; Zujewski JA
Clin Cancer Res; 2007 Mar; 13(6):1644-7. PubMed ID: 17363516
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the treatment of pediatric brain tumors.
Gururangan S; Friedman HS
Oncology (Williston Park); 2004 Nov; 18(13):1649-61; discussion 1662, 1665-6, 1668. PubMed ID: 15648297
[TBL] [Abstract][Full Text] [Related]
17. Precision Medical Approaches to the Diagnoses and Management of Brain Metastases.
Chukwueke UN; Brastianos PK
Curr Treat Options Oncol; 2019 May; 20(6):49. PubMed ID: 31062107
[TBL] [Abstract][Full Text] [Related]
18. Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.
Chen TC; Da Fonseca CO; Schönthal AH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598140
[TBL] [Abstract][Full Text] [Related]
19. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract][Full Text] [Related]
20. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]